Insulin Delivery devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 April 01
SKU : MD718
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What's driving the growth of this market ?
The rising prevalence of diabetes and advancements in insulin delivery technology are key growth factors.
Who are the key players in Insulin Delivery Devices Market ?
Major players are Novo Nordisk, GlaxoSmithKline, Bristol-Myers Squibb, Becton Dickinson, Eli Lilly and Company, Merck & Co., AstraZeneca, Sanofi, Roche Holding AG, Amgen, Johnson & Johnson, Abbott Laboratories and Tandem diabetes care.
What is the Projected CAGR value of the Insulin Delivery Devices Market ?
Insulin Delivery Devices Market is expected to grow at a CAGR of 7.1% during the forecast period (2024-2031).
Related Reports
medical-devicesDrug Delivery Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 January 17
Starting from
$4350
medical-devicesConnected Drug Delivery Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 21
Starting from
$4350
medical-devicesImplantable Drug Delivery Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 29
Starting from
$3750
medical-devicesVaccine Delivery Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 02
Starting from
$4350
medical-devicesDrug Delivery Infusion System Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 26
Starting from
$4350
medical-devicesNovel Drug Delivery System Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 October 06
Starting from
$4350